How AI Improves Consistency and Rigor in Healthcare Decision-Making

Patient experience data plays an increasing role in health system decision-making. The challenge for the healthcare industry stakeholders now is how to capture and effectively use this information at scale. AI can transform patient-generated and real-world data into more usable evidence, but trust, data quality, and governance will determine whether this tool has a meaningful impact.

The Global Payer Forum 2026 focused on an urgent question: how can decision-making better reflect what matters to patients while still supporting long-term sustainability? Organized by Alira Health in partnership with leading academic institutions, the event featured a two-part webinar series.

This article focuses on key takeaways from the second session, “How AI-Enabled Tools Can Strengthen Patient Data and Decision-Making.” These insights point to a central conclusion: AI can improve the consistency and rigor of healthcare decision-making, but only when applied to well-defined problems, supported by high-quality data, and embedded within trusted governance and incentive structures.

1. Start With the Problem, Not Technology

Healthcare stakeholders should resist treating AI as the objective. AI is a tool, and its value depends entirely on the problem it is meant to solve. The challenge for life sciences companies is often the failure to capture patient data in a way that is relevant, continuous, structured, and useful in decision-making. The current industry focus in AI can push organizations into launching technology initiatives without clearly defining the underlying need. The more practical approach is to begin with a specific challenge, such as diagnosis, trial design, patient monitoring, or real-world evidence generation, and then ask where AI truly adds value.

2. Patient Data Quality Determines AI Value

Healthcare systems today have more patient data than ever before, generated through wearables, telemetry, home monitoring, genomic analysis, and digital platforms. However, that does not automatically mean they have better evidence. Stakeholders need high-quality patient data: longitudinal rather than static, structured rather than buried in narrative form, and relevant to what decision-makers need to know. AI extract structured insights from unstructured inputs, but poor data will still produce poor results. High-quality data capture, curation, and stewardship are prerequisites for smarter use of AI. By structuring patient data and standardizing its use, AI reduces variability in how evidence is interpreted, improving consistency and methodological rigor in decision-making.

3. AI Adds Value Across the Healthcare Lifecycle

AI has significant potential across the healthcare lifecycle. In research and development, it helps generate hypotheses, identify trial populations, and improve study design. In regulatory and access settings, it can support the translation of real-world data into real-world evidence and help connect patient experience to value demonstration. In care delivery, areas where AI can expand access and improve system performance include triage, back-office efficiency, earlier diagnosis, remote monitoring, and hospital-at-home models. AI is useful not because it replaces human judgment, but because it can make complex processes more responsive, timely, and informed by patient-level realities.

4. Trust and Governance Determine Adoption

AI adoption will stall without trust. Patients want to know how their data is used, how their privacy is protected, and whether AI-supported decisions are transparent enough to understand and challenge. Clinicians and payers want to know on what basis a recommendation was made. Consent, anonymity, explainability, and governance are essential conditions rather than secondary considerations. Regulations and institutional frameworks need to evolve in a way that supports innovation without leaving users uncertain about responsibilities, boundaries, and acceptable use.

5. Incentives Drive Data Sharing and Outcomes-Based Care

High-quality patient data will not flow consistently across the system unless stakeholders have a reason to share it and to trust the resulting use. Social and economic incentives for patients, providers, and organizations include the need to show the value created when patients contribute to insights. AI also links to a broader shift from paying for products toward paying for outcomes. If healthcare systems want to finance therapies according to the real value delivered, then they need stronger mechanisms for measuring outcomes in practice. AI may be the tool, but only if incentives, data standards, and institutional capabilities evolve together.

AI will not standardize healthcare decision-making by default. Its impact depends on disciplined problem definition, high-quality data, and aligned incentives. Organizations that treat AI as infrastructure rather than experimentation will be better positioned to deliver consistent, patient-centered decisions at scale.

The Global Payer Forum is an annual online event that examines key trends that reshape access to healthcare innovation. The 2026 edition featured two free, interactive webinars designed to foster cross-stakeholder collaboration, learning, practical insight sharing, and actionable guidance for decision-makers navigating this evolving landscape.

Global Payer Forum 2026 was organized by Alira Health, sponsored by Takeda, and presented in partnership with Universitat Pompeu Fabra and UCL Global Business School for Health.